Navigation Links
Sunrise Reports Preliminary Selected Financial and Operating Data for Fourth-Quarter 2007
Date:3/3/2008

hat this charge

should be recorded in 2006, instead of 2007 as previously disclosed.

No assurance can be given that additional pre-tax charges will not be

required in subsequent periods.

Other Anticipated Pre-Tax Charges and Impairments

-- Impairment of Long-Lived Assets. The Company expects to record an

impairment charge of $14.6 million in 2006 related to four small senior

living communities, two of which the Company acquired in 1996 and two

of which the Company acquired in 1999. The Company also expects to

record an impairment charge of approximately $4.0 million in 2007

related to another senior living community acquired in 1999.

-- Acquired Venture. As disclosed in the Company's press release dated

November 9, 2007, in the third quarter of 2005, Sunrise acquired a 20

percent interest in a venture and entered into management agreements

for the 16 communities owned by the venture. In conjunction with this

transaction, the Company guaranteed to fund shortfalls between actual

net operating income and a specified level of net operating income up

to $7 million per year through July 2010. The Company paid $12 million

to the venture to enter into the management agreements, which was

recorded as an intangible asset and is being amortized over the 30-year

life of the management agreements. The $12 million was placed into a

reserve account by the venture, and the first $12 million of shortfalls

were to be funded from that reserve account by the venture. The Company

determined that shortfalls will exceed the amount held in the reserve

account. As a result, the Company expected to record a pre-tax charge

of $21 million. The Company has now determined that the entire $21

million charge will be recorded in 2006.

-- Trinity Hospice Impairment. As
'/>"/>

SOURCE Sunrise Senior Living, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Sunrise Announces Release Date for Fourth-Quarter Preliminary Selected Financial and Operating Data
2. Sunrise to Unveil New Residence for Seniors at Clayton on the Park
3. Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy
4. Eclipsys Sunrise Radiology Helps Trinitas Hospital Achieve Financial Outcome Improvements
5. Sunrise Senior Living Opens First Custom-Built Community for Early, Mid and Late Stage Alzheimers Care Programs
6. Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007
7. Eclipsys Sunrise Acute Care Receives CCHIT Certification
8. Sunrise Settles Litigation Regarding Its 2007 Annual Meeting
9. SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America
10. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
11. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...ewswire-USNewswire/ -- Tonight, in a partisan vote...,s version of the government takeover of health ca... in this bill; like the public option, employer an...or elective abortion, which is the most onerous an...vides subsidies for private plans that cover elect...
(Date:11/21/2009)...ey Provisions of Legislation, Continues Push for P...Ill., Nov. 21 With th...rk Affordable Health Care for America Act (H.R. 39...lation forward, Congress has taken decisive steps ...day, AARP hosted an educational forum to discuss t...
(Date:11/21/2009)...ll, president and chief executive officer of the A...following statement regarding the inclusion of cog...ual wellness for Medicare beneficiaries in "T...; that was introduced last night: , ...-- Eric J. Hall, president and chief executive off...
(Date:11/20/2009)...Newswire-USNewswire/ -- The American Academy of A...re reform legislation released this week to contai...ndividual coverage mandate. The actuaries said tha...ze adverse selection stemming from more restrictiv..., "The individual mandate language should be st...
(Date:11/20/2009)...ire-USNewswire/ -- The American Dental Association...ration (FDA) to establish appropriate classificati...oncern about the safety of whitening products that...fessional consultation or examination by a dentist...mically based tooth whitening or bleaching agents ...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...SOFT (OCuSOFT,Inc.), a company specializing in oph...lmologists and optometrists, is pleased to announc...., to its Optometric Scientific,Advisory Board. *...d to playing a key role in the center,s developmen...
...ograms and support services in Los ...Lupus Foundation of,America (LFA) and Maybelline(R...ly Foundation hosted the First Annual "Butterflies...than 300,celebrities and guests who helped raise f...
...Dental,Association (ADA) House of Delegates called...nderstand the materials used to create dental fill... ease of placement, durability,and relative costs ...her outlets, the,association wants to ensure its a...
...high Circumference, LAS VEGAS, Oct. 2 Ariana Cos... America to offer Syneron,s VelaShape, the only,FD...inimize cellulite.,VelaShape uses elos technology ...e by almost an inch. Dr. Michael Belfiore of Aria...
...rns based on prostate cancer biopsy were found to ...this measurement could help predict the risk of pr... research published in the October 3 issue of JAMA...umors) of the prostate based on the patterns of pr...
...rch announced the,findings of the latest wave of i...urvey was completed in late June and found that ju...erage are definitely or very likely,to switch to M... switch, general satisfaction with their current,c...
Other Medicine News:Health News:Stars Shine on 'Butterflies Over Hollywood' for Lupus Foundation of America 2Health News:ADA Calls for Scientifically Accurate Patient Brochure Explaining Filling Choices 2Health News:Ariana First to Offer VelaShape in North America 2Health News:Using additional biopsy-scoring data may help determine prostate cancer prognosis 2
(Date:11/20/2009)...0 Smith & Nephew ( S...nnounce the signing of a technology development co...e that may lead to the creation of a fracture fixa...t of the limbs of soldiers who sustain battlefield...esearch Projects Agency (DARPA), the central resea...
(Date:11/19/2009).... 19 BioCryst Pharmaceut...ricing of a public offering of 5,000,000 shares of... gross proceeds of $48.75 million. All of the sha...ffective shelf registration statement previously f... BioCryst has also granted the underwriters a 30-d...
(Date:11/19/2009)...ov. 19 /PRNewswire-Asia/ -- ScinoPharm, a leading ...ts (APIs), announced that its,Tainan facility has ...from,SafeBridge(R) Consultants, Inc. The Certifica...ncy in the safe handling of potent active,pharmace... laboratories and,production areas used for the ma...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 1Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 2Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 3Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 4Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 1Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 2Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 3Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 1New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 5New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 6
...tive Disease Week(R) 2008, NATICK, Mass. and SAN ...: BSX ) today announced results from an,internati...vorable safety,and clinical utility data for its S...s extensive visual access to the biliary tract. Re...Chen, M.D., Division of Gastroenterology,& Hepatol...
...estive Disease Week -, CAMBRIDGE, Mass. and NEW Y...rly Microbia, Inc.) and Forest,Laboratories, Inc. ...data,from a Phase 2b randomized, double-blind, pla...icacy of linaclotide in patients with chronic,cons...t linaclotide met its,primary endpoint. The study ...
Other Medicine Technology:Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 2Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 3Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 4Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 2Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 4Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 6
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
Clear-Therm™ with Flextube
Medicine Products: